Intra-arterial chemotherapy for head and neck cancer: Is there a verdict?

Cancer

Volumn 116, Issue 9, 2010, Pages 2068-2070

  Robbins, K Thomas ^a   Howell, Stephen B ^b   Williams, James Scott ^c  

^a SOUTHERN ILLINOIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^c Memphis Neurosciences Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; SODIUM THIOSULFATE;

ARTERY BLOOD FLOW; CAROTID ARTERY; CATHETERIZATION; EDITORIAL; HEAD AND NECK CANCER; PRIORITY JOURNAL; PROGNOSIS; VIRUS INFECTION; WART VIRUS;

ANTINEOPLASTIC AGENTS; CISPLATIN; CLINICAL TRIALS AS TOPIC; DRUG ADMINISTRATION ROUTES; HEAD AND NECK NEOPLASMS; HUMANS; INFUSIONS, INTRA-ARTERIAL;

EID: 77951448559     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.24930     Document Type: Editorial

References (15)

1. Robbins KT, Kumar P, Wong FSH, et al. Targeted chemo-radiation for advanced head and neck cancer: analysis of 213 patients. Head Neck. 2000;22:687-693.
2. Robbins KT, Kumar P, Harris J, et al. Supradose intra-arterial cisplatin and concurrent radiation therapy for the treatment of stage IV head and neck squamous cell carcinoma is feasible and efficacious in a multi-institutional setting: results of Radiation Therapy Oncology Group Trial 9615. J Clin Oncol. 2005;23:1447-1454. (Pubitemid 46260032)
3. Balm AJM, Rasch CRN, Schornagel JH, et al. High-dose superselective intra-arterial cisplatin and concomitant radiation (RADPLAT) for advanced head and neck cancer. Head Neck. 2004;26:485-493. (Pubitemid 38702635)
4. Kerber CW, Wong WH, Howell SB, Hanchett C, Robbins KT. An organ-preserving selective arterial chemotherapy strategy for head and neck cancer. Am J Neuroradiol. 1998;19:935-941. (Pubitemid 30415783)
5. Los G, Blommaert FA, Barton R, et al. Selective intra-arterial infusion of high-dose cisplatin in patients with advanced head and neck cancer resulting in high tumor platinum concentrations and cisplatin-DNA adduct formation. Cancer Chemotherapy Pharmacology. 1995;37:150-154.
6. Hoebers FJP, Pluim D, Verheij M, et al. Prediction of treatment outcome by cisplatin-DNA adduct formation in patients with stage III/IV head and neck squamous cell carcinoma, treated by concurrent cisplatin-radiation (RADPLAT). Int J Cancer. 2006;119:750-756. (Pubitemid 44051437)
7. D'Souza G, Kreimer AR, Viscidi R, et al. Case-control study of human papillomavirus and oropharyngeal cancer. N Engl J Med. 2007;356:1944-1956. (Pubitemid 46740304)
8. Mellin H, Friesland S, Lewensohn R, Dalianis T, Munck-Wikland E. Human papillomavirus (HPV) DNA in tonsillar cancer: clinical correlates, risk of relapse, and survival. Int J Cancer. 2009;89:300-304.
9. Schwartz SR, Yueh B, McDougall JK, Daling JR, Schwartz SM. Human papillomavirus infection and survival in oral squamous cell cancer: a population-based study. Otolaryngol Head Neck Surg. 2001;125:1-9. (Pubitemid 33661083)
10. Sedaghat AR, Zhang Z, Begum S, et al. Prognostic significance of human papillomavirus in oropharyngeal squamous cell carcinomas. Laryngoscope. 2009;119:1542-1549.
11. Adelstein DJ, Li Y, Adams GL, et al. An intergroup phase III comparison of standard radiation therapy and 2 schedules of concurrent chemoradiotherapy in patients with unresectable squamous cell head and neck cancer. J Clin Oncol. 2003;21:92-98.
12. Vokes EE, Haraf DJ, Kies MS. The use of concurrent chemotherapy and radiotherapy for locoregionally advanced head and neck cancer. Semin Oncol. 2000;Aug;27(4 suppl 8):34-38.
13. Posner MR, Haddad RI, Wirth L, et al. Induction chemotherapy in locally advanced squamous cell cancer of the head and neck: evolution of the sequential treatment approach. Semin Oncol. 2004;31:778-785. (Pubitemid 39602683)
14. Bonner JA, Harari PM, Giralt J, et al. Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck. N Engl J Med. 2006;354:567-578. (Pubitemid 43209104)
15. Rasch CRN, Hauptmann M, Schornagel J, et al. Intra-Arterial Versus Intravenous Chemoradiation for Advanced Head and Neck Cancer: Results of a Randomized Phase 3 Trial. Cancer. 2010;118:2159-2165.